Načítá se...
A multitude of kinases—Which are the best targets in treating rheumatoid arthritis?
Small-molecule kinase inhibitors are increasingly taking center stage in the quest for new drugs for the treatment of rheumatoid arthritis (RA). By targeting kinases, many of which orchestrate multiple signaling pathways, small-molecule inhibitors can exert potent anti-inflammatory and immunomodulat...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2879404/ https://ncbi.nlm.nih.gov/pubmed/20510239 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rdc.2010.02.005 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|